We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Advisory Council on the Misuse of Drugs (ACMD) has published a report reviewing the availability and use of naloxone in the UK, a drug used to reverse opioid overdose.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister of State for Crime Reduction and Policing on the interim podiatrists supply proposal.
The report "Preventing drug use among vulnerable groups of people", commissioned by the Home Office, has been published by the ACMD.
The government commissions the ACMD to advise on the appropriate classification and scheduling of Isotonitazene and related compounds.
The government responds to the ACMD reports on cannabis-based products for medicinal use (CBPMs) in humans.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister of State for Crime Reduction and Policing on Sunosi advice.
Barriers to Research working group calls for written evidence about barriers to legitimate research for controlled drugs, excluding synthetic cannabinoids.
Advisory Council on the Misuse of Drugs (ACMD) call for evidence on cannabinoids in CBD products.
The Advisory Council on the Misuse of Drugs (ACMD) has reappointed 4 experts in their fields to serve their third term on the council.
A review of the evidence of use and harms of novel benzodiazepines.
First published during the 2019 to 2022 Johnson Conservative government
Three new members of the Advisory Council for the Misuse of Drugs (ACMD) have been announced today.
ACMD public request for written evidence on cognition enhancers (also known as ‘nootropics’ or ‘study drugs’).
Forms for members of the public to provide written evidence on young people’s drug use and naloxone provision.
A letter from the Minister of State for Fire and Policing to the ACMD, in response to the recommendation to Schedule Epidyolex.
Letter from the ACMD Barriers to Research working group to collect written evidence from researchers about barriers to legitimate research with controlled drugs.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Home Secretary advising on COVID-19 emergency measures to enable the supply of controlled drugs.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Home Secretary in response to the 6 January letter on GHB and GBL.
Letter to the Home Office regarding the appropriate Schedule for the cannabis-based product for medicinal use, Epidyolex, under the Misuse of Drugs Regulations 2001.
This report advises government on the number and nature of known fentanyl analogues, risk factors, pharmacology, toxic effects and misuse and associated harms.
Letter to the Home Secretary from the Chair of the Advisory Council on the Misuse of Drugs, outlining our self-commissioned workstreams planned for 2020.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).